Follicular Lymphoma Clinical Trials in Hackensack, New Jersey

4 studies are recruiting for follicular lymphoma in Hackensack, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

    Researchers are looking for new ways to treat follicular lymphoma (FL). A standard (usual) treatment for FL includes a targeted therapy called rituximab and chemotherapy. In this study, researchers want to learn if giving a study medicine called MK-1045 and rituximab can treat FL. MK-1045 is a type…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    John Theurer Cancer Center at Hackensack University Medical Center ( Site 1311), Hackensack, New Jersey
    Locations
    25 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT07634471 on ClinicalTrials.gov

  2. A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

    The purpose of this study is to find out if mosunetuzumab is an effective treatment in people with follicular lymphoma that was recently diagnosed and have not yet received any treatments for their disease.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Hackensack Meridian Health (Data collection only), Hackensack, New Jersey
    Locations
    9 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT05389293 on ClinicalTrials.gov

  3. A Long-term Extension Study of PCI-32765 (Ibrutinib)

    The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolled in ibrutinib studies that have been completed according to the parent protocol, are actively rece…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Hackensack University Medical Center, Hackensack, New Jersey
    Locations
    175 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT01804686 on ClinicalTrials.gov

  4. Study of SGR-1505 in Mature B-Cell Neoplasms

    The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD) and/or recommended dose (RD) of SGR-1505.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Regional Cancer Care Associates, Hackensack, New Jersey
    Locations
    36 in total
    Run by
    Schrödinger, Inc.

    See if you can join NCT05544019 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.